NIH-funded research NIH-funded research

Using ultrasound to activate ketamine for treating chronic pain without opioids

Official title: Clinical Translation of Ultrasonic Ketamine Uncaging for Non-Opioid Therapy of Chronic Pain

Funded at Stanford University · NIH-11090278 · Data updated 2026-11-12

This study is looking at a new way to help people with chronic pain by using sound waves to activate ketamine in the brain, aiming to ease the emotional struggles that come with pain and improve overall treatment, which could also help those dealing with opioid use issues.

More Chronic Pain research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionStanford University
NIH-funded
Lab location1 site (Stanford, United States)
Project startSeptember 30, 2019
Project endJuly 31, 2026
Funding year2024
Award (this year)$129,968
NIH project number3UG3NS115637-03S1
Project IDNIH-11090278 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from chronic pain, particularly those with significant emotional distress related to their condition.

Less likely to help

Patients who do not experience chronic pain or those with conditions that do not have an affective component may not benefit from this research.

What this research studies

This research investigates a novel approach to treating chronic pain by using ultrasonic technology to activate ketamine in the brain, specifically targeting the anterior cingulate cortex. The goal is to alleviate the emotional distress associated with chronic pain, which can significantly affect how patients perceive and experience pain. By focusing on the affective component of pain, this method aims to improve overall treatment outcomes for patients suffering from chronic pain and potentially other neuropsychiatric disorders. The research also explores the implications for treating opioid use disorder by addressing mood disturbances that often lead to relapse.

Why it matters

Potential benefit: If successful, this research could provide a non-opioid therapy option for chronic pain management, reducing reliance on traditional pain medications.

How similar studies have gone: While the use of ketamine for pain management is established, the specific approach of ultrasonic uncaging is novel and has not been extensively tested in clinical settings.

Where this research is happening

  • Stanford University
    Stanford, United States
    Active

Researchers

  • Principal investigator: Airan, Raag D — Stanford University
  • Study coordinator: Airan, Raag D

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.